首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷藥物遞輸設備電子醫療設備內視鏡檢查設備

市場調查報告書

商品編碼

1909128

智慧藥丸給藥系統市場規模、佔有率和成長分析（按類型、組件、應用、最終用戶、疾病適應症和地區分類）—產業預測（2026-2033 年）

Smart Pills Drug Delivery Market Size, Share, and Growth Analysis, By Type, By Component, By Application, By End User, By Disease Indication, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月29日 | 出版商:

SkyQuest | 英文 197 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球智慧藥丸藥物傳輸市場規模預計在 2024 年達到 23.2 億美元，從 2025 年的 25.6 億美元成長到 2033 年的 57 億美元，在預測期（2026-2033 年）內複合年成長率為 10.5%。

全球智慧藥丸給藥市場受到消化器官系統疾病和慢性疾病（例如大腸直腸癌和糖尿病）日益普遍的顯著影響，這些疾病需要持續監測和精準治療。患者越來越傾向於選擇侵入性較小的診斷方法，這使得智慧藥丸成為傳統方法的有效替代方案。內視鏡技術的進步（例如高清成像和無線資料傳輸）進一步提高了這些口服設備的效率和功能。此外，遠端患者監護的趨勢也與改善依從性追蹤和臨床療效的創新解決方案的需求相契合。然而，該市場也面臨著許多挑戰，例如高成本、監管障礙和資料安全問題，這些都可能阻礙智慧藥丸在醫療保健領域的成長和廣泛應用。

全球智慧藥丸藥物傳輸市場促進因素

胃腸道疾病（包括克隆氏症、結腸癌和糖尿病等慢性疾病）發生率的不斷上升，顯著推動了智慧藥丸給藥市場的擴張。由於這些疾病需要持續監測和精準診斷，因此智慧藥丸對於早期發現和標靶給藥至關重要。此外，它們在改善這些疾病的長期管理策略方面也發揮關鍵作用，最終提供更有效的治療方案。隨著人們對疾病治療創新解決方案的需求日益成長，智慧藥丸正逐漸成為現代醫學領域不可或缺的工具，有助於改善患者預後並提高整體醫療效率。

全球智慧藥丸藥物輸送市場面臨的限制因素

全球智慧藥丸給藥市場面臨許多挑戰，其中最主要的原因是這些先進技術高成本，限制了許多病患和醫療機構的取得。智慧藥丸的生產和部署成本高昂，對醫院而言構成了一大障礙，尤其是在預算緊張的情況下。此外，缺乏廣泛的保險覆蓋加劇了這個問題，成為智慧藥丸技術普及應用的一大阻礙。因此，這些經濟限制阻礙了智慧藥丸在醫療保健領域的大規模應用，也限制了智慧藥丸為許多需要創新治療方案的患者帶來的益處。

全球智慧藥丸藥物傳輸市場趨勢

全球智慧藥丸市場正經歷一場變革，人工智慧 (AI) 的融入徹底改變了患者照護。這些創新膠囊能夠分析即時數據並提供預測性見解，透過在異常情況惡化之前識別出來，從而增強慢性病管理。人工智慧也能透過推薦最佳用藥時間來支援個人化治療方案，提升病患的用藥依從性和治療效果。這些智慧藥丸可與電子健康記錄無縫整合，協助精準醫療轉型，實現個人化的醫療保健體驗。這種模式轉移使人工智慧增強型智慧藥丸成為未來醫藥發展領域的前沿力量。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Medtronic plc
Olympus Corp
Philips NV
CapsoVision Inc.
Jinshan Science & Tech
Check-Cap Ltd.
etectRx Inc.
Otsuka Pharmaceutical Co.
HQ Inc.
IntroMedic Co.
BodyCap Medical
Proteus Digital Health
RF Tracking Systems
AnX Robotica
Chongqing Science & Tech
Karl Storz SE & Co. KG
Fujifilm Holdings Corp
Boston Scientific Corp

結論與建議

簡介目錄

Product Code: SQMIG35A3073

Global Smart Pills Drug Delivery Market size was valued at USD 2.32 Billion in 2024 and is poised to grow from USD 2.56 Billion in 2025 to USD 5.7 Billion by 2033, growing at a CAGR of 10.5% during the forecast period (2026-2033).

The Global Smart Pills Drug Delivery Market is significantly influenced by the increasing prevalence of gastrointestinal and chronic diseases, such as colorectal cancer and diabetes, which require continuous monitoring and precise treatment. Patients are increasingly favoring less invasive diagnostic methods, positioning smart pills as a viable alternative to traditional approaches. Technological advancements in endoscopy, including enhanced imaging and wireless data transmission, have further improved the efficiency and functionality of these ingestible devices. Additionally, the shift towards remote patient monitoring aligns with the need for innovative solutions that enhance compliance tracking and clinical outcomes. However, the market faces challenges such as high device costs, regulatory hurdles, and concerns surrounding data security, which can hinder the growth and adoption of smart pills in healthcare settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Pills Drug Delivery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Pills Drug Delivery Market Segments Analysis

Global Smart Pills Drug Delivery Market is segmented by Type, Component, Application, End User, Disease Indication and region. Based on Type, the market is segmented into Capsule Endoscopy, Patient Monitoring Smart Pills and Drug-Delivery Smart Pills. Based on Component, the market is segmented into Ingestible Sensor, Wearable Receiver/Patch and Software & Analytics Platform. Based on Application, the market is segmented into Diagnostic Imaging, Medication Adherence Tracking and Targeted Drug Delivery. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostic Centers, Home Healthcare and Research Institutes. Based on Disease Indication, the market is segmented into Gastro-intestinal Disorders, Oncology, Obesity & Metabolic Disorders and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Smart Pills Drug Delivery Market

The increasing incidence of gastrointestinal disorders, including Crohn's disease, colorectal cancer, and chronic illnesses like diabetes, significantly contributes to the expansion of the smart pills drug delivery market. These conditions require continuous monitoring and precise diagnostics, making smart pills crucial for early detection and targeted drug administration. Additionally, they play a vital role in improving long-term management strategies for these diseases, ultimately offering a more effective approach to healthcare. As the demand for innovative solutions in disease treatment grows, smart pills are positioned as essential tools in the realm of modern medicine, enhancing patient outcomes and overall healthcare efficiency.

Restraints in the Global Smart Pills Drug Delivery Market

The Global Smart Pills Drug Delivery market faces significant challenges due to the high costs associated with these advanced technologies, which limit their accessibility for numerous patients and healthcare providers. The steep expenses linked to the manufacturing and deployment of smart pills create obstacles for hospitals, especially in budget-constrained settings. Furthermore, the lack of extensive insurance coverage exacerbates this issue, presenting a notable barrier to the widespread adoption of smart pill technology. Consequently, these financial constraints hinder the potential for large-scale implementation in the healthcare sector, restricting the benefits that smart pills could offer to many individuals in need of innovative treatment solutions.

Market Trends of the Global Smart Pills Drug Delivery Market

The Global Smart Pills Drug Delivery market is witnessing a transformative trend as the integration of artificial intelligence (AI) into smart pills revolutionizes patient care. These innovative capsules will capabilities to analyze real-time data and offer predictive insights, enhancing the management of chronic diseases by identifying anomalies before they escalate. Furthermore, AI will facilitate tailored medication regimens by recommending optimal dosing times, thereby improving adherence and outcomes. Seamlessly linking with electronic health records, these smart pills support a shift towards precision medicine, enabling a personalized healthcare experience. This paradigm shift positions AI-enhanced smart pills at the forefront of future pharmaceutical advancements.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Customer Buying Behavior Analysis
Case Studies

Global Smart Pills Drug Delivery Market Size by Type & CAGR (2026-2033)

Market Overview
Capsule Endoscopy
Patient Monitoring Smart Pills
Drug-Delivery Smart Pills

Global Smart Pills Drug Delivery Market Size by Component & CAGR (2026-2033)

Market Overview
Ingestible Sensor
Wearable Receiver/Patch
Software & Analytics Platform

Global Smart Pills Drug Delivery Market Size by Application & CAGR (2026-2033)

Market Overview
Diagnostic Imaging
Medication Adherence Tracking
Targeted Drug Delivery

Global Smart Pills Drug Delivery Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals & Clinics
Diagnostic Centers
Home Healthcare
Research Institutes

Global Smart Pills Drug Delivery Market Size by Disease Indication & CAGR (2026-2033)

Market Overview
Gastro-intestinal Disorders
Oncology
Obesity & Metabolic Disorders
Others

Global Smart Pills Drug Delivery Market Size & CAGR (2026-2033)

North America (Type, Component, Application, End User, Disease Indication)
- US
- Canada
Europe (Type, Component, Application, End User, Disease Indication)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Component, Application, End User, Disease Indication)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Component, Application, End User, Disease Indication)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Component, Application, End User, Disease Indication)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corp
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips NV
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CapsoVision Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jinshan Science & Tech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Check-Cap Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
etectRx Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Otsuka Pharmaceutical Co.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HQ Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IntroMedic Co.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BodyCap Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Proteus Digital Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RF Tracking Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AnX Robotica
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chongqing Science & Tech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Karl Storz SE & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corp
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corp
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments